Equity Capital Markets
Crinetics Pharmaceuticals, Inc.
10/24
|
$500.0 Million
Âé¶¹´«Ã½ served as bookrunner for Crinetics Pharmaceuticals, Inc. on its CMFO
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma